Symbols

SNOA

Sonoma Pharmaceuticals·NASDAQ

--(--)

7.22 / 10

Outperform

Analyst coverage is absent. Fund‑flow rating is good (7.22/10) with mixed patterns: small and large investors net positive, but overall and block flows trend negative. The positive flow score tempers the lack of analyst support.

Fund Flow Rating

What is the market sentiment for SNOA?

SNOA holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.22/10 (Outperform).